home / stock / atai / atai quote
Last: | $1.91 |
---|---|
Change Percent: | -3.54% |
Open: | $2.05 |
Close: | $1.91 |
High: | $2.05 |
Low: | $1.91 |
Volume: | 1,014,477 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.91 | $2.05 | $1.91 | $2.05 | $1.91 | 1,014,477 | 04-18-2024 |
$1.98 | $2.18 | $1.98 | $2.2 | $1.98 | 1,473,352 | 04-17-2024 |
$2.15 | $2.07 | $2.15 | $2.205 | $2.0401 | 1,211,619 | 04-16-2024 |
$2.07 | $2.28 | $2.07 | $2.37 | $2.07 | 1,753,458 | 04-15-2024 |
$2.3 | $2.44 | $2.3 | $2.55 | $2.22 | 1,631,050 | 04-12-2024 |
$2.47 | $2.45 | $2.47 | $2.5 | $2.37 | 1,056,066 | 04-11-2024 |
$2.43 | $2.3 | $2.43 | $2.5 | $2.26 | 1,555,775 | 04-10-2024 |
$2.39 | $2.48 | $2.39 | $2.585 | $2.38 | 1,639,442 | 04-09-2024 |
$2.6 | $2.49 | $2.6 | $2.64 | $2.39 | 2,394,769 | 04-08-2024 |
$2.45 | $2.45 | $2.45 | $2.5492 | $2.32 | 2,525,323 | 04-05-2024 |
$2.51 | $2.44 | $2.51 | $2.85 | $2.38 | 8,157,155 | 04-04-2024 |
$2.39 | $1.95 | $2.39 | $2.48 | $1.83 | 9,942,136 | 04-03-2024 |
$1.87 | $1.82 | $1.87 | $1.88 | $1.77 | 928,436 | 04-02-2024 |
$1.86 | $1.97 | $1.86 | $1.97 | $1.76 | 2,066,738 | 04-01-2024 |
$1.97 | $1.805 | $1.97 | $2.04 | $1.8 | 2,959,300 | 03-29-2024 |
$1.97 | $1.805 | $1.97 | $2.04 | $1.8 | 2,959,300 | 03-28-2024 |
$1.79 | $1.8 | $1.79 | $1.83 | $1.68 | 1,342,180 | 03-27-2024 |
$1.73 | $1.7 | $1.73 | $1.76 | $1.67 | 883,619 | 03-26-2024 |
$1.66 | $1.62 | $1.66 | $1.715 | $1.6101 | 1,175,929 | 03-25-2024 |
$1.63 | $1.65 | $1.63 | $1.6698 | $1.6 | 898,082 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
ATAI Life Sciences N.V. Company Name:
ATAI Stock Symbol:
NASDAQ Market:
ATAI Life Sciences N.V. Website:
BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered intranasally. BPL-003 was shown to be safe and well-tolerated with a predictable pharmacokinetic profile and a reliable induction of subjective psychedelic effects with s...
Legislators in the House of Representatives in the state of Missouri have awarded preliminary approval to a budget measure that would allocate $10 million from opioid settlement funds to study grants focused on researching psilocybin’s use in treating opioid-use disorder. The initiativ...
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Re...